Filtrar

Publicações

Patterns of Care for Metastatic Pancreatic Cancer: Real World Data from the Brazilian Private Healthcare System (PHS)

Abstract

Treatment of metastatic pancreatic cancer (MPC) remains a challenge for oncologists worldwide, since not many innovations were added lately. From 1997 to 2011 (when the pivotal study on FOLFIRINOX was published), patients were essentially treated with gemcitabine. Recent publications show new options, such as OFF regimen. Nevertheless, there is a ...

Healthcare Access Differences Between Public and Private Insurance Coverage Among Patients with Depression in Brazil

Abstract

The healthcare sector in Brazil is divided in two types. The public sector (used by 75% of the population) is a free, universal healthcare system known as Unified Health System or SUS. The private sector (PHS) is used by 25% of people, enrolled in private healthcare plans that are either employer provided or individual contracted. PHS offers ...

Exploratory Analysis of APAC Values Versus Recommended Treatment Guidelines for Metastatic Non-Small Cell Lung Cancer (mNSCLC) in The Brazilian Public Healthcare System

Abstract

Reimbursement of oncology treatments by the Brazilian Public Health System (SUS) is controlled by the Authorization for High Complexity Procedures (APAC) System. Each line of treatment has an APAC code associated with a specific reimbursement value that should cover all drug expenses for one month. However, with innovation and more expensive drugs ...

Patterns of Care with Biological Drugs for Ankylosing Spondylitis: Real-World Data from The Private Healthcare Market in Brazil

Absttract

Ankylosing spondylitis (AS) is a progressive, incurable rheumatologic disease with worldwide prevalence of 0.1-0.5%. Since January 2012, the Brazilian Agency for Supplementary Healthcare (ANS - Agência Nacional de Saúde Suplementar) declared the coverage of intravenous biological drugs (BD) mandatory for patients with AS, rheumatoid arthritis, ...

From Law to Reality: Measuring Time-to-Access of CONITEC approved Drugs in Brazilian Public Health care System (SUS) in The State of Parana

Abstract

Brazilian Federal Law 12.401/2011 created the National Committee for Health Technology Incorporation (CONITEC) and defined criteria and deadlines for health technology (HT) incorporation in public health system (SUS). CONITEC advises the Brazilian Ministry of Health about HT incorporation or disinvestment in SUS and clinical guidelines ...

Treatment Patterns and Budgetary Impact of Chemotherapy Drugs in a Brazilian Private Health Plan (PHP)

Abstract

According to GLOBOSCAN 2012 and WHO, 14.1 million new cancer cases and 8.2 million deaths occurred worldwide in 2012. In Brazil, the incidence of the disease is also increasing as population ages, with 576,000 new cases of cancer expected in 2015. Despite the significant impact of disease and need for monitoring ...

Access Inequalities Between Private and Public Insurance Among Cancer Patients: Results of a National Survey in Brazil

Abstract

Cancer represents a burden of disease with an increasing incidence worldwide. Approximately 576,000 new cases of cancer are expected each year in Brazil. About 70% of the population in Brazil is covered only by the public health system (PuHS). Previous studies showed inequalities for overall health access with ...

Defining Market Access in Brazil: the Pharma Professionals’ Perspective

Abstract

Innovation in healthcare has become increasingly expensive making it difficult for pharmaceutical companies (PHARMAS) to have their products reimbursed. The Brazilian context is even more complex due to the current economic crisis, complex incorporation pathway in the private market and accelerated growth of the ...

Individual and Societal Burden of Non-Adherence to Antidepressants in Brazil

Abstract

Depression is a serious public health problem related to high social costs and risk of suicide, also the leading cause of disability affecting 350 million people worldwide according to the World Health Organization (WHO). Although efficacious and cost-effective treatments are available, non-adherence is very common ...

Trends of Research Related to Brazil Published at ISPOR Meetings: a Bibliometric Analysis from 1998 to 2014

Abstract

Since 2004, the Brazilian government has been implementing some actions, such as the National Policy of Health Technologies Management, to develop and disseminate Health Technology Assessment (HTA) within the country. The Commission for Technologies Incorporation (CITEC – later renamed CONITEC) ...